Oncology Corporate Profile
Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders.
View additional information on product candidates here »
© Caribou Publishing. All rights reserved. Reproduction in whole or in part is prohibited.